🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07512102
Recruiting Not applicable

Comparison of Low- Versus High-Level Angle Kappa Compensation Strategies in SMILE Using the VisuMax 800: A Randomized Clinical Trial

NCT07512102 · tracked via the Priya Life Science China tracker
Sponsor
Zhongshan Ophthalmic Center, Sun Yat-sen University
Phase
Not applicable
Started
2026-04-08
Last updated
2026-07-07

Condition(s) studied

MyopiaRefractive Ametropia

Investigational drug(s) / intervention(s)

Apply high compensation to the Kappa angle.Apply low compensation to the Kappa angle.

Apply high compensation to the Kappa angle.: SMILE PRO is an upgraded version/procedural designation of SMILE (Small Incision Lenticule Extraction) performed on the ZEISS VisuMax 800 femtosecond laser platform. It remains, in essence, an all-femtosecond corneal refractive procedure. Its basic principle is to use a femtosecond laser to create a lenticule within the corneal stroma together with a small incision, and then remove the lenticule through that incision, thereby reshaping the corneal curvature to correct myopia and astigmatism. In the high-level compensation group, a high level of compensation for the kappa angle was applied during the preoperative parameter input.

Apply low compensation to the Kappa angle.: SMILE PRO is an upgraded version/procedural designation of SMILE (Small Incision Lenticule Extraction) performed on the ZEISS VisuMax 800 femtosecond laser platform. It is essentially an all-femtosecond corneal refractive procedure. Its basic principle is to use a femtosecond laser to create a lenticule within the corneal stroma and a small incision, and then remove the lenticule through the incision, thereby reshaping the corneal curvature to correct myopia and astigmatism. In the low-level compensation group, a low level of kappa-angle compensation was applied during the preoperative parameter input.

Study summary

The goal of this clinical trial is to compare two intraoperative kappa-angle compensation strategies during small incision lenticule extraction (SMILE) using the VisuMax 800 platform in patients with relatively large kappa-angle offsets.

Angle kappa represents the difference between the visual axis and the pupil center. In patients with a large offset, pupil-centered treatment may lead to decentration of the optical zone, which can induce higher-order aberrations and affect postoperative visual quality. The VisuMax 800 system allows intraoperative adjustment of the treatment center based on the measured offset, making different compensation strategies possible.

The main questions this study aims to answer are:

Does low kappa-angle compensation (50%) result in lower postoperative higher-order aberrations than high compensation (100%)? Does the compensation strategy influence visual acuity, refractive outcomes, contrast sensitivity, and subjective visual quality after SMILE? Are the measurements obtained from different diagnostic devices consistent when evaluating kappa-related parameters?

Researchers will compare SMILE with low compensation to SMILE with high compensation to determine which strategy provides better optical quality and visual performance.

Participants will:

Undergo SMILE surgery using either low or high kappa-angle compensation Complete scheduled postoperative examinations at 1 month, 3 months, and 6 months Receive measurements of visual acuity, refraction, higher-order aberrations, contrast sensitivity, and patient-reported visual outcomes Be monitored for safety outcomes and adverse events during follow-up

Eligibility

Sex
ALL
Min age
18 Years
Max age
40 Years
Healthy volunteers
No
Inclusion Criteria: 1. Age range: 18 - 40 years old. Patients with stable refractive status for \>= 1 year, having myopia or myopic astigmatism, with refractive power within the range of SMILE procedure. 2. Normal corneal morphology and corneal thickness meeting the surgical requirements. 3. Best corrected visual acuity (CDVA) before surgery \>= 1.0. 4. The kappa angle-related offset coordinates (x, y) obtained before surgery, with the absolute value of either \|x\| or \|yl\| of any eye \>= 0.20mm. 5. Voluntary to undergo SMILE surgery on the VISUMAX800 platform, understanding the random grouping scheme and signing the informed consent form. Exclusion Criteria: 1. History of prior ocular surgery, significant ocular trauma, or presence of corneal or ocular diseases that may affect the safety of refractive surgery. 2. Severe systemic diseases that may affect ocular healing or surgical safety. 3. Females who are pregnant or lactating. 4. Inability to cooperate as required to complete the procedure or follow-up visits.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Zhongshan Ophthalmic Center Guangzhou Guangdong Recruiting

More Zhongshan Ophthalmic Center, Sun Yat-sen University trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07512102 on ClinicalTrials.gov ↗ ← All trials in China